JW Pharmaceutical Corporation (KRX:001065)

Market Cap	707.93B +31.4%
Revenue (ttm)	775.30B +7.8%
Net Income	61.51B -5.4%
EPS	2,534.00 -4.2%
Shares Out	n/a
PE Ratio	11.51
Forward PE	n/a
Dividend	675.00 (2.41%)
Ex-Dividend Date	Mar 31, 2026

Volume	3
Average Volume	548
Open	26,600
Previous Close	26,350
Day's Range	26,550 - 26,600
52-Week Range	26,000 - 30,300
Beta	1.16
RSI	37.82
Earnings Date	Mar 20, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001065

Financial Performance

In 2025, JW Pharmaceutical's revenue was 775.30 billion, an increase of 7.77% compared to the previous year's 719.38 billion. Earnings were 61.51 billion, a decrease of -5.43%.